John Valgus

897 total citations
36 papers, 643 citations indexed

About

John Valgus is a scholar working on Geriatrics and Gerontology, Family Practice and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John Valgus has authored 36 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 7 papers in Family Practice and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John Valgus's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Medication Adherence and Compliance (7 papers) and Patient Safety and Medication Errors (5 papers). John Valgus is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Medication Adherence and Compliance (7 papers) and Patient Safety and Medication Errors (5 papers). John Valgus collaborates with scholars based in United States and Canada. John Valgus's co-authors include Stephen A. Bernard, Larry W. Buie, Lindsey B. Amerine, Benyam Muluneh, Aimee Faso, Sally Barbour, George J. Knafl, Howard L. McLeod, Márcia Van Riper and Mary W Roederer and has published in prestigious journals such as Journal of Clinical Oncology, Supportive Care in Cancer and Annals of Pharmacotherapy.

In The Last Decade

John Valgus

36 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Valgus United States 14 252 174 141 111 93 36 643
Ana Paula Martins Portugal 14 233 0.9× 82 0.5× 87 0.6× 99 0.9× 27 0.3× 54 707
Sylvia Bartel United States 13 251 1.0× 205 1.2× 130 0.9× 58 0.5× 27 0.3× 20 767
Richard R. Cline United States 14 103 0.4× 152 0.9× 138 1.0× 339 3.1× 100 1.1× 40 751
Carole Chambers Canada 17 127 0.5× 151 0.9× 52 0.4× 102 0.9× 18 0.2× 58 677
Vérane Schwiertz France 14 170 0.7× 103 0.6× 52 0.4× 46 0.4× 28 0.3× 31 607
Niesha Griffith United States 10 120 0.5× 138 0.8× 51 0.4× 117 1.1× 27 0.3× 21 402
Eric M. Tichy United States 14 87 0.3× 175 1.0× 49 0.3× 103 0.9× 31 0.3× 40 615
Scott W. Savage United States 13 133 0.5× 89 0.5× 28 0.2× 39 0.4× 28 0.3× 28 411
Sabrina W. Cole United States 10 111 0.4× 92 0.5× 20 0.1× 88 0.8× 52 0.6× 14 361
Autumn D. Zuckerman United States 12 156 0.6× 112 0.6× 216 1.5× 190 1.7× 16 0.2× 71 599

Countries citing papers authored by John Valgus

Since Specialization
Citations

This map shows the geographic impact of John Valgus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Valgus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Valgus more than expected).

Fields of papers citing papers by John Valgus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Valgus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Valgus. The network helps show where John Valgus may publish in the future.

Co-authorship network of co-authors of John Valgus

This figure shows the co-authorship network connecting the top 25 collaborators of John Valgus. A scholar is included among the top collaborators of John Valgus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Valgus. John Valgus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deal, Allison M., et al.. (2021). A Pharmacist-Led Oral Chemotherapy Program’s Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes. Journal of the Advanced Practitioner in Oncology. 12(2). 148–157. 14 indexed citations
2.
Morbitzer, Kathryn A., et al.. (2021). Decision-making framework for an acute care clinical pharmacist productivity model: Part 1. American Journal of Health-System Pharmacy. 5 indexed citations
3.
Jean, Stéphanie, et al.. (2020). Evaluation of telepharmacy and the use of a gravimetric technology–assisted workflow system for remote sterile product pharmacist checks. American Journal of Health-System Pharmacy. 77(7). 560–567. 10 indexed citations
4.
Valgus, John, Kristin Weitzel, Josh F. Peterson, Daniel J. Crona, & Christine M. Formea. (2019). Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit. American Journal of Health-System Pharmacy. 76(8). 521–529. 7 indexed citations
5.
Chun, Danielle S., Aimee Faso, Hyman B. Muss, et al.. (2019). Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapy. Journal of Oncology Pharmacy Practice. 26(5). 1156–1163. 11 indexed citations
6.
Roberts, Patricia, et al.. (2018). Evaluation of a gravimetric-based technology-assisted workflow system on hazardous sterile product preparation. American Journal of Health-System Pharmacy. 75(17). 1286–1292. 15 indexed citations
7.
Valgus, John, et al.. (2018). Infusion reactions following administration of intravenous rolapitant at an academic medical center. Journal of Oncology Pharmacy Practice. 25(7). 1776–1783. 6 indexed citations
8.
Amerine, Lindsey B., et al.. (2017). Implementation of a longitudinal early immersion student pharmacist health system internship program. Currents in Pharmacy Teaching and Learning. 9(3). 421–426. 6 indexed citations
9.
Westfall, Kristen M., et al.. (2017). The Impact on Resource Utilization of Supportive Care Consults on Patients at the University of North Carolina Hospital, 2010–2012. Journal of Palliative Medicine. 21(2). 216–219. 7 indexed citations
10.
Valgus, John, Eric A. Singer, Scott R. Berry, & W. Kimryn Rathmell. (2013). Ethical Challenges: Managing Oncology Drug Shortages. Journal of Oncology Practice. 9(2). e21–e23. 27 indexed citations
11.
Valgus, John, et al.. (2013). Converting to Transdermal Fentanyl: Avoidance of Underdosing. Journal of Palliative Medicine. 16(4). 409–411. 5 indexed citations
12.
Valgus, John, et al.. (2011). Integration of a clinical pharmacist into the hematology–oncology clinics at an academic medical center. American Journal of Health-System Pharmacy. 68(7). 613–619. 48 indexed citations
13.
Roederer, Mary W, Márcia Van Riper, John Valgus, George J. Knafl, & Howard L. McLeod. (2011). Knowledge, Attitudes and Education of Pharmacists Regarding Pharmacogenetic Testing. Personalized Medicine. 9(1). 19–27. 67 indexed citations
14.
Valgus, John, et al.. (2010). Use of a pharmacist/nurse model for the delivery of supportive care in adult oncology clinics at the University of North Carolina Hospital.. Journal of Clinical Oncology. 28(15_suppl). 9166–9166. 3 indexed citations
15.
Buie, Larry W. & John Valgus. (2008). Bevacizumab: A Treatment Option for Recurrent Glioblastoma Multiforme. Annals of Pharmacotherapy. 42(10). 1486–1490. 33 indexed citations
16.
17.
Valgus, John. (2003). What’s new in antifungals?. Current Infectious Disease Reports. 5(1). 16–21. 11 indexed citations
18.
Brock, Tina, et al.. (2003). Pharmacogenomics: implications and considerations for pharmacists. Pharmacogenomics. 4(3). 321–330. 13 indexed citations
19.
Valgus, John. (2001). Caspofungin. . The First of a New Class of Antifungal Agents. Cancer Practice. 9(6). 314–316. 3 indexed citations
20.
Valgus, John. (1999). Emerging Therapies for Breast Cancer. Cancer Practice. 7(2). 100–103. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Paula Martins Breakdown of academic impact, for papers by Sylvia Bartel Breakdown of academic impact, for papers by Richard R. Cline Breakdown of academic impact, for papers by Carole Chambers Breakdown of academic impact, for papers by Vérane Schwiertz Breakdown of academic impact, for papers by Niesha Griffith Breakdown of academic impact, for papers by Eric M. Tichy Breakdown of academic impact, for papers by Scott W. Savage Breakdown of academic impact, for papers by Sabrina W. Cole Breakdown of academic impact, for papers by Autumn D. Zuckerman
Rankless by CCL
2026